Trials / Completed
CompletedNCT03604861
An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
Remission From Chronic Opioid Use: Studying Environmental and SocioEconomic Factors on Recovery-The RECOVER Study®
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 534 (actual)
- Sponsor
- Indivior Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The RECOVER Study will examine clinical, environmental and socioeconomic factors in recovery from opioid use disorder (OUD) over a 24-month period following exit from a Phase III clinical program for a buprenorphine extended-release injection (RBP-6000). The study population will consist of participants from studies NCT02357901 (RB-US-13-0001) and NCT02510014 (RB-US-13-0003). The RECOVER study will characterize OUD subjects' recovery process as they transition from the controlled clinical trial environment to the real world setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Not applicable - no defined intervention | Participants who received at least one injection of RBP-6000 or placebo and either withdrew from or completed the Phase III clinical program which included studies NCT02357901 (RB-US-13-0001) and NCT02510014 (RB-US-13-0003) were eligible for the RECOVER Study. |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2019-03-01
- Completion
- 2019-03-01
- First posted
- 2018-07-30
- Last updated
- 2019-04-18
Locations
35 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03604861. Inclusion in this directory is not an endorsement.